Fundraising Fox

Solarea Bio

Waltham, US · Founded 2017 · Delaware corporation · 5 known investors

Biotech

Founders & leadership

IL
ILISSA LARIMOREExecutive
GT
GERARDO TOLEDONamed on SEC filing
ESERIC SCHOTT
ERIC SCHOTTNamed on SEC filing

Board

AJANULA JAYASURIYA
ANULA JAYASURIYAinBoard directorInvestor at DigitalDx Ventures
MW
MATTHEW WALKERBoard director
NBNEAL BHADKAMKAR
NEAL BHADKAMKARinBoard directorGeneral Partner at Bold Capital Partners
GS
GREGORY SIECZKIEWICZBoard director

Investors · 5

Olive Tree CapitalBoston
Rising TidePacifica
Bold Capital Partnersreported · 2 sourcesSanta Monicavia Neal Bhadkamkar · board
DigitalDx VenturesreportedMenlo Parkvia Anula Jayasuriya · board
S2G InvestmentsreportedChicago · $1M – $5M

Reported raises · per SEC filings

Form D private placements

$37.2M disclosed across 4 rounds · 2020–2025

▶$9.9MraisedNov 2025 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • NEAL BHADKAMKARDirector
  • MATTHEW WALKERDirector
  • ANULA JAYASURIYADirector
  • GREGORY SIECZKIEWICZDirector
  • CATHERINE BALSAM-SCHWABERExecutive Officer, Director
  • ERIC SCHOTTExecutive Officer
Amount sold
$9.9M
First sale
Nov 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedSep 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ANULA JAYASURIYADirector
  • MATTHEW WALKERDirector
  • NEAL BHADKAMKARDirector
  • ILISSA LARIMOREExecutive Officer
  • GREGORY SIECZKIEWICZDirector
  • GERARDO TOLEDOExecutive Officer, Director
  • ERIC SCHOTTExecutive Officer
Amount sold
$1M
First sale
Aug 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedMay 2023 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ANULA JAYASURIYADirector
  • GREGORY SIECZKIEWICZDirector
  • MATTHEW WALKERDirector
  • GERARDO TOLEDOExecutive Officer, Director
  • NEAL BHADKAMKARDirector
  • ERIC SCHOTTExecutive Officer
Offering amount
$25M
Amount sold
$15M
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.3MraisedSep 2020 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • GREGORY SIECZKIEWICZDirector
  • GERARDO TOLEDOExecutive Officer, Director
  • ERIC SCHOTTExecutive Officer
  • MATTHEW WALKERDirector
  • NEAL BHADKAMKARDirector
  • ANULA JAYASURIYADirector
Offering amount
$14.8M
Amount sold
$11.3M
First sale
Aug 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Solarea Bio Appoints New Chief Executive Officer - BioSpacebiospace.com · Oct 2025Solarea Bio raises $15M in series B funding roundnutraingredients.com · May 2023Solarea Bio, a biotech company that creates therapeutic medical foods from beneficial microbes, raises $15 million - Global Wellness Summitglobalwellnesssummit.com · May 2023Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partnersprnewswire.com · Oct 2020

Frequently asked questions

Who are Solarea Bio's investors?
Solarea Bio's investors include Olive Tree Capital, Rising Tide, Bold Capital Partners, DigitalDx Ventures, S2G Investments.
How much funding has Solarea Bio raised?
Solarea Bio has disclosed $37.2M raised across 4 rounds.
Where is Solarea Bio headquartered?
Solarea Bio is headquartered in Waltham, US.